Latest Articles

Publication Date
All News Scientific
Successful Pregnancy and Delivery After Detecting an Exceptionally Early-Formed Implantation Window Using Endometrial Receptivity Analysis: A Case Report - Cureus

Successful Pregnancy and Delivery After Detecting an Exceptionally Early-Formed Implantation Window Using Endometrial Receptivity Analysis: A Case Report Cureus

Published: June 4, 2025, 11:50 p.m.
Read Full Article
LGL: Paula S. Cousins Ovarian and Endometrial Cancer Foundation - yourerie.com

LGL: Paula S. Cousins Ovarian and Endometrial Cancer Foundation yourerie.com

Published: June 4, 2025, 9:50 p.m.
Read Full Article
Correlation Between Hormonal Modulation and Pregnancy Outcomes: The Impact of Estrogen Priming and Endometrial Receptivity in Intrauterine Insemination - Cureus

Correlation Between Hormonal Modulation and Pregnancy Outcomes: The Impact of Estrogen Priming and Endometrial Receptivity in Intrauterine Insemination Cureus

Published: June 4, 2025, 3:34 p.m.
Read Full Article
Paula S. Cousins Ovarian & Endometrial Cancer Foundation, Inc. is this week’s winner of Loving Giving Local - yourerie.com

Paula S. Cousins Ovarian & Endometrial Cancer Foundation, Inc. is this week’s winner of Loving Giving Local yourerie.com

Published: June 4, 2025, 2:22 p.m.
Read Full Article
Upregulation of miR-183 inhibits the invasion and migration of endometrial stromal cells in endometriosis patients by downregulating Ezrin - Frontiers

Upregulation of miR-183 inhibits the invasion and migration of endometrial stromal cells in endometriosis patients by downregulating Ezrin Frontiers

Published: June 3, 2025, 6:52 p.m.
Read Full Article
Impact of the Microcystic, Elongated, and Fragmented (MELF) Invasion Pattern on prognosis in Endometrial Carcinoma: A Comprehensive Meta-Analysis - Frontiers

Impact of the Microcystic, Elongated, and Fragmented (MELF) Invasion Pattern on prognosis in Endometrial Carcinoma: A Comprehensive Meta-Analysis Frontiers

Published: June 3, 2025, 2:36 p.m.
Read Full Article
Genmab advances with lower dose of Rina-S in endometrial cancer trials - Investing.com Canada

Genmab advances with lower dose of Rina-S in endometrial cancer trials Investing.com Canada

Published: June 3, 2025, 8:43 a.m.
Read Full Article
Genmab advances with lower dose of Rina-S in endometrial cancer trials - Investing.com

Genmab advances with lower dose of Rina-S in endometrial cancer trials Investing.com

Published: June 3, 2025, 8:41 a.m.
Read Full Article
Genmab A/S (GMAB) Reports 50% Response Rate With Rina-S in Advanced Endometrial Cancer - Insider Monkey

Genmab A/S (GMAB) Reports 50% Response Rate With Rina-S in Advanced Endometrial Cancer Insider Monkey

Published: June 3, 2025, 5 a.m.
Read Full Article
Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - BioSpace

Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial BioSpace

Published: June 2, 2025, 11:48 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!